The Daily Report is a compilation of COVID-19 (coronavirus) news briefs from around the world to help life sciences and health care companies stay current in this challenging time.
...more
4/21/2020
/ Collaboration ,
Coronavirus/COVID-19 ,
Defense Production Act ,
EU ,
Federal Trade Commission (FTC) ,
Fraud ,
Life Sciences ,
Medical Devices ,
Pharmaceutical Industry ,
Public Health Emergency ,
Supply Chain
Prepare for global data class actions has been moved. In the wake of the COVID-19 epidemic, there is an unfortunate increase in the cyber-security risks businesses may face. Our global team will help you best prepare for the...more
4/8/2020
/ Class Action ,
Collective Actions ,
Collective Redress ,
Compliance ,
Coronavirus/COVID-19 ,
Cross-Border ,
Cybersecurity ,
Data Breach ,
Data Privacy ,
EU ,
General Data Protection Regulation (GDPR) ,
Member State ,
Mexico ,
Regulatory Oversight ,
Risk Management ,
Russia ,
United States ,
Webinars
Businesses are increasingly turning to trade secrets as a mechanism to protect their innovations and know-how. In some cases, trade secrets offer an attractive alternative to patent protection. Companies also recognize the...more
2/19/2020
/ Administrative Proceedings ,
Asia ,
Competition ,
Confidential Information ,
Criminal Penalties ,
Criminal Sanctions ,
EU ,
Foreign Investment ,
Infringement ,
Intellectual Property Protection ,
Misappropriation ,
Penalties ,
Trade Secrets ,
UK Brexit ,
Unfair Competition ,
United States-Mexico-Canada Agreement (USMCA)
The General Data Protection Regulation 2016/679 (GDPR) provides means to enforce provisions related to personal data processing by you as a data controller or data processor. It introduces collective actions everywhere in...more
11/22/2019
/ Burden of Proof ,
Class Action ,
Cybersecurity ,
Data Breach ,
Data Processors ,
Data Protection ,
EU ,
EU Data Protection Laws ,
European Commission ,
Evidence ,
Forum Shopping ,
General Data Protection Regulation (GDPR) ,
International Data Transfers ,
Litigation Strategies ,
Personal Data ,
Personally Identifiable Information ,
Private Right of Action ,
Risk Management ,
Russia
Whilst political uncertainty may have businesses’ attention fixed, the Hogan Lovells Global Survey on Digital Regulation: ‘A Turning Point for Tech’ suggests that tech companies should be looking elsewhere. During yesterday’s...more
10/31/2019
/ 5G Network ,
Big Tech ,
Business Model ,
Competition ,
Copyright ,
Corporate Taxes ,
Cybersecurity ,
Data Protection ,
Digital Platforms ,
Enforcement Programs ,
EU ,
Freedom of Expression ,
General Data Protection Regulation (GDPR) ,
Innovative Technology ,
Privacy Concerns ,
Regulatory Agenda ,
Regulatory Oversight ,
Regulatory Standards ,
United Arab Emirates (UAE)
Innovation in the life sciences and health care industries is occurring at a dizzying pace. Five years ago, anti-PD-1 antibodies from Merck and BMS had yet to be approved, CAR-T therapies were still in small-scale clinical...more
4/4/2018
/ 3D Printing ,
Acquisitions ,
Artificial Intelligence ,
Biologics ,
Biosimilars ,
Biotechnology ,
Blockchain ,
Cyber Attacks ,
Cybersecurity ,
Data Breach ,
Digital Health ,
Distributed Ledger Technology (DLT) ,
Drug Pricing ,
Emerging Markets ,
EU ,
General Data Protection Regulation (GDPR) ,
Generic Drugs ,
Innovation ,
Life Sciences ,
Medical Reimbursement ,
Mergers ,
Over The Counter Derivatives (OTC) ,
Pharmaceutical Industry ,
Prescription Drugs ,
Private Equity ,
Regulatory Oversight ,
Supply Chain ,
Transfer Pricing ,
UK Brexit ,
Yates Memorandum